Finance leader for the ~$5B Lab Solutions segment of AvantorLead a global finance team of 180+ members supporting 300,000 customer sites and 5 million+ products in 180 countries

• Lead the global commercial finance team (~40 FTE’s) in a highly complex healthcare landscape with multiple stakeholders, including federal, state, and local governments; health care providers; insurance carriers; aggregated physician groups, clinicians; retail and e-commerce entities• Member of the Finance Leadership Team and the Extended Global Leadership Team• Secretary for the Global Pricing Council• Managed forum for leadership to approve global pricing decisions with an impact of more than $500K• Key member in all major presentations – Monthly performance reviews, Lender presentations, Private Equity Operating Council review, Deal meetings, Strategic planning, Debt restructuring, and Liquidity reviews• Key member in linking financial forecasts and the demand plan• Responsible for all aspects of commercial finance globally• Advise commercial leadership on issues related to performance of the business and the delivery of revenue and EBITDA targets• Responsible for providing detailed commentary, analysis and insights into commercial performance, including proactive assessment of impending issues

Finance Director for the Medical Division (2019-2021) & Life Sciences Division (2017-2019)

Member of the corporate finance team following the purchase of Axalta from DuPont by Carlyle

Senior Financial Analyst in the R&D and Goverment Contracts teams

Leadership development program with rotational assignments over a two year period